Peng Yi-Hao, Liao Wei-Chih, Su Ching-Hua, Chen Hsuan-Ju, Hsia Te-Chun, Chu Chia-Chen, Liu Chin-Jung, Kao Chia-Hung
Department of Respiratory Therapy, China Medical University Hospital, Taichung, Taiwan.
Allergy Asthma Proc. 2015 Sep-Oct;36(5):e92-8. doi: 10.2500/aap.2015.36.3869.
We evaluated the risk of asthma development in adult patients with inflammatory bowel disease (IBD) in a nationwide population.
A retrospective cohort study was conducted by using data retrieved from the Taiwan National Health Insurance Research Database. Patients, ages 20 year or older, with newly diagnosed IBD between 2000 and 2005 were identified and randomly frequency-matched (based on sex, age, and index year) with four times the number of enrollees without IBD from the general population. Both cohorts were followed up until the end of 2011 to examine the incidence of asthma. Cox proportional hazard regression analysis was used to measure the hazard ratios (HR) of asthma in the IBD cohort compared with that in the non-IBD cohort.
The IBD and non-IBD cohorts comprised 5260 patients with IBD and 21,040 participants, respectively. After adjustment for covariates, the IBD cohort exhibited a 1.50-fold increased risk for asthma (HR 1.50, [95% confidence interval {CI}, 1.32-1.71]). Further analysis according to the two major forms of IBD revealed that the adjusted HR of asthma was 1.46 (95% CI, 1.03-2.07) and 1.50 (95% CI, 1.31-1.72) in patients with ulcerative colitis and Crohn's disease, respectively, compared with the non-IBD cohort.
After adjustment for comorbidities, patients with IBD were associated with a higher subsequent risk of asthma.
我们在全国范围内评估了成年炎症性肠病(IBD)患者患哮喘的风险。
利用从台湾国民健康保险研究数据库中检索到的数据进行了一项回顾性队列研究。确定了2000年至2005年间新诊断为IBD的20岁及以上患者,并将其与普通人群中4倍数量的未患IBD的入组者进行随机频率匹配(基于性别、年龄和索引年份)。对两个队列进行随访至2011年底,以检查哮喘的发病率。采用Cox比例风险回归分析来测量IBD队列中哮喘的风险比(HR)与非IBD队列中哮喘风险比的差异。
IBD队列和非IBD队列分别包括5260例IBD患者和21040名参与者。在对协变量进行调整后,IBD队列患哮喘的风险增加了1.50倍(HR 1.50,[95%置信区间{CI},1.32 - 1.71])。根据IBD的两种主要类型进行的进一步分析显示,与非IBD队列相比,溃疡性结肠炎患者和克罗恩病患者哮喘的调整后HR分别为1.46(95% CI,1.03 - 2.07)和1.50(95% CI,1.31 - 1.72)。
在对合并症进行调整后,IBD患者随后患哮喘的风险更高。